SGHT News and Press, Sight Sciences Inc. From 02/17/22

MENLO PARK, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced the launch of its “Don...

Sight Sciences (NASDAQ: SGHT) only recently made its public debut. Since the company's initial public offering last summer, shares have plunged by nearly 50%. Now, it's not uncommon for newly public companies to see shares plunge, even after a strong entrance to the market. Is this ...

MENLO PARK, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced preliminary unaudited financial resul...

Sight Sciences (NASDAQ:SGHT) has added ~1.2% in the pre-market after announcing that the FDA has issued 510(k) clearance for the company’s TearCare System for meibomian gland dysfunction (MGD), the main reason for dry eye disease (DED). The FDA has greenlighted TearCare Syste...

MENLO PARK, Calif., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced U.S. Food and Drug Administra...

Point Roberts, WA and Delta, BC - November 19, 2021 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Life Sciences and Mining. Today's stocks have been added to our lists of free stock...

MENLO PARK, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced plans to participate in the ...

MENLO PARK, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced publication in Clinical ...

Sight Sciences Inc. (SGHT) Q3 2021 Results Conference Call November 10, 2021 04:30 PM ET Company Participants Philip Taylor - Gilmartin Group Paul Badawi - Co-Founder, CEO Jesse Selnick - CFO Shawn O'Neil - Chief Commercial Officer Conference Call Participants Cecilia Furlong - Morgan Stanley...

Image source: The Motley Fool. Sight Sciences, Inc. (NASDAQ: SGHT) Q3 2021 Earnings Call Nov 10, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Sight Sciences, Inc. (SGHT) Q3 2021 Earnings Call Transcript